Medpace Holdings, INC Form 4 insider transactions

Director Fred B. Davenport Jr. of Medpace Holdings, Inc. exercised stock options and sold a portion of the acquired shares on April 24, 2025.

Cornelius P. McCarthy III, a director at Medpace Holdings, Inc., reports the acquisition of 50 shares of common stock through the exercise of restricted stock units on March 31, 2025.

Director Robert Kraft reports the vesting of restricted stock units in Medpace Holdings, Inc.

Director Brian T. Carley reports a transaction involving Medpace Holdings, Inc. common stock and restricted stock units.

CEO August J. Troendle reports exercising stock options and acquiring/disposing of Medpace Holdings (MEDP) common stock on March 7, 2025.

Jesse J. Geiger, President of Medpace Holdings, reports the acquisition of stock options.

Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reports acquisition of stock options.

Susan E. Burwig, Executive VP of Operations at Medpace Holdings, Inc., reports the acquisition of 11,017 shares through a stock option grant.

Medpace Holdings CFO Kevin M. Brady reports the acquisition of stock options and disposal of common stock.

Stephen Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reports purchasing 2 shares of common stock at $326.11 on February 27, 2025, increasing his holdings to 13,343 shares.

Director Brian T. Carley exercised stock options and sold shares of Medpace Holdings, Inc. on February 24, 2025.

Director Cornelius P. McCarthy III of Medpace Holdings, Inc. reports the exercise of stock options and vesting of restricted stock units on December 31, 2024.

Director Robert Kraft reports the vesting and subsequent disposal of restricted stock units in Medpace Holdings, Inc.

Brian T. Carley, a director at Medpace Holdings, reported the vesting of restricted stock units on December 31, 2024.

Medpace Holdings President, Jesse J. Geiger, exercised stock options for 15,000 shares at a price of $32.05 per share.

Medpace Holdings director Cornelius P. McCarthy III acquired 198 restricted stock units, which vest in four equal installments throughout 2025.

Robert O. Kraft, a director at Medpace Holdings, acquired 227 restricted stock units on November 29, 2024.

Medpace Holdings director Brian T. Carley acquired 249 restricted stock units, each representing a contingent right to receive one share of MEDP common stock, on November 29, 2024.

Medpace Holdings Executive Vice President, Operations, Susan E. Burwig, exercised stock options for 7,500 shares at $32.05 per share on November 19, 2024.

Cornelius P. McCarthy III, a director at Medpace Holdings, exercised stock options on September 30, 2024, acquiring 62 shares of common stock.

Director Robert Kraft of Medpace Holdings reports the vesting and conversion of restricted stock units into common stock.

Director Brian T. Carley reported the vesting of 78 restricted stock units of Medpace Holdings, Inc. on September 30, 2024.

Director Robert Kraft exercised stock options and sold shares of Medpace Holdings (MEDP) on August 22nd and 23rd, 2024.

Executive VP of Operations at Medpace Holdings, Susan Burwig, exercised stock options and was granted restricted stock units (RSUs) according to a recent SEC Form 4 filing.

Medpace Holdings President Jesse J. Geiger reported the acquisition of 10,000 restricted stock units (RSUs) on August 5, 2024, vesting in full on August 5, 2029, subject to continued employment.

Kevin M. Brady, CFO & Treasurer of Medpace Holdings, Inc., reports the disposition of 6,000 shares of common stock and acquisition of 7,500 restricted stock units.

Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reports the acquisition of 7,500 restricted stock units.

August J. Troendle, CEO of Medpace Holdings, reports the acquisition of 50,000 stock options and indirect beneficial ownership of 4,733,019 shares through Medpace Investors, LLC.

Director Dani S. Zander acquired stock options in Medpace Holdings, Inc. on July 1, 2024.

Cornelius P. McCarthy III, a director at Medpace Holdings, exercised stock options and acquired 62 shares of common stock on June 30, 2024.